The Extent to Which Lipid Nanoparticles Require Apolipoprotein E and Low-Density Lipoprotein Receptor for Delivery Changes with Ionizable Lipid Structure. 2022

Kalina Paunovska, and Alejandro J Da Silva Sanchez, and Melissa P Lokugamage, and David Loughrey, and Elisa Schrader Echeverri, and Ana Cristian, and Marine Z C Hatit, and Philip J Santangelo, and Kun Zhao, and James E Dahlman
Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University School of Medicine, Atlanta, Georgia 30332, United States.

Lipid nanoparticles (LNPs) have delivered therapeutic RNA to hepatocytes in humans. Adsorption of apolipoprotein E (ApoE) onto these clinical LNP-mRNA drugs has been shown to facilitate hepatocyte entry via the low-density lipoprotein receptor (LDLR). Since ApoE-LDLR trafficking is conserved in mice, non-human primates, and humans, characterizing this mechanism eased clinical transition. Recently, LNPs have delivered mRNA to non-hepatocytes in mice and non-human primates, suggesting they can target new cell types via ApoE- and LDLR-independent pathways. To test this hypothesis, we quantified how 60 LNPs delivered mRNA with cell type resolution in wild-type mice and three knockout mouse strains related to lipid trafficking: ApoE-/-, LDLR-/-, and PCSK9-/-. These data suggest that the hydrophobic tail length of diketopiperazine-based lipids can be changed to drive ApoE- and LDLR-independent delivery in vivo. More broadly, the results support the hypothesis that endogenous LNP trafficking can be tuned by modifying lipid chemistry.

UI MeSH Term Description Entries
D008077 Lipoproteins, LDL A class of lipoproteins of small size (18-25 nm) and light (1.019-1.063 g/ml) particles with a core composed mainly of CHOLESTEROL ESTERS and smaller amounts of TRIGLYCERIDES. The surface monolayer consists mostly of PHOSPHOLIPIDS, a single copy of APOLIPOPROTEIN B-100, and free cholesterol molecules. The main LDL function is to transport cholesterol and cholesterol esters to extrahepatic tissues. Low-Density Lipoprotein,Low-Density Lipoproteins,beta-Lipoprotein,beta-Lipoproteins,LDL(1),LDL(2),LDL-1,LDL-2,LDL1,LDL2,Low-Density Lipoprotein 1,Low-Density Lipoprotein 2,LDL Lipoproteins,Lipoprotein, Low-Density,Lipoproteins, Low-Density,Low Density Lipoprotein,Low Density Lipoprotein 1,Low Density Lipoprotein 2,Low Density Lipoproteins,beta Lipoprotein,beta Lipoproteins
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001057 Apolipoproteins E A class of protein components which can be found in several lipoproteins including HIGH-DENSITY LIPOPROTEINS; VERY-LOW-DENSITY LIPOPROTEINS; and CHYLOMICRONS. Synthesized in most organs, Apo E is important in the global transport of lipids and cholesterol throughout the body. Apo E is also a ligand for LDL receptors (RECEPTORS, LDL) that mediates the binding, internalization, and catabolism of lipoprotein particles in cells. There are several allelic isoforms (such as E2, E3, and E4). Deficiency or defects in Apo E are causes of HYPERLIPOPROTEINEMIA TYPE III. Apo-E,Apo E,Apo E Isoproteins,ApoE,Apolipoprotein E Isoproteins,Apoprotein (E),Apoproteins E,Isoproteins, Apo E,Isoproteins, Apolipoprotein E
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D053758 Nanoparticles Nanometer-sized particles that are nanoscale in three dimensions. They include nanocrystaline materials; NANOCAPSULES; METAL NANOPARTICLES; DENDRIMERS, and QUANTUM DOTS. The uses of nanoparticles include DRUG DELIVERY SYSTEMS and cancer targeting and imaging. Nanocrystalline Materials,Nanocrystals,Material, Nanocrystalline,Materials, Nanocrystalline,Nanocrystal,Nanocrystalline Material,Nanoparticle
D018345 Mice, Knockout Strains of mice in which certain GENES of their GENOMES have been disrupted, or "knocked-out". To produce knockouts, using RECOMBINANT DNA technology, the normal DNA sequence of the gene being studied is altered to prevent synthesis of a normal gene product. Cloned cells in which this DNA alteration is successful are then injected into mouse EMBRYOS to produce chimeric mice. The chimeric mice are then bred to yield a strain in which all the cells of the mouse contain the disrupted gene. Knockout mice are used as EXPERIMENTAL ANIMAL MODELS for diseases (DISEASE MODELS, ANIMAL) and to clarify the functions of the genes. Knockout Mice,Mice, Knock-out,Mouse, Knockout,Knock-out Mice,Knockout Mouse,Mice, Knock out

Related Publications

Kalina Paunovska, and Alejandro J Da Silva Sanchez, and Melissa P Lokugamage, and David Loughrey, and Elisa Schrader Echeverri, and Ana Cristian, and Marine Z C Hatit, and Philip J Santangelo, and Kun Zhao, and James E Dahlman
April 2000, The Biochemical journal,
Kalina Paunovska, and Alejandro J Da Silva Sanchez, and Melissa P Lokugamage, and David Loughrey, and Elisa Schrader Echeverri, and Ana Cristian, and Marine Z C Hatit, and Philip J Santangelo, and Kun Zhao, and James E Dahlman
January 2008, Analytical biochemistry,
Kalina Paunovska, and Alejandro J Da Silva Sanchez, and Melissa P Lokugamage, and David Loughrey, and Elisa Schrader Echeverri, and Ana Cristian, and Marine Z C Hatit, and Philip J Santangelo, and Kun Zhao, and James E Dahlman
January 2019, Biological & pharmaceutical bulletin,
Kalina Paunovska, and Alejandro J Da Silva Sanchez, and Melissa P Lokugamage, and David Loughrey, and Elisa Schrader Echeverri, and Ana Cristian, and Marine Z C Hatit, and Philip J Santangelo, and Kun Zhao, and James E Dahlman
December 2000, Biochimica et biophysica acta,
Kalina Paunovska, and Alejandro J Da Silva Sanchez, and Melissa P Lokugamage, and David Loughrey, and Elisa Schrader Echeverri, and Ana Cristian, and Marine Z C Hatit, and Philip J Santangelo, and Kun Zhao, and James E Dahlman
December 1984, The Journal of biological chemistry,
Kalina Paunovska, and Alejandro J Da Silva Sanchez, and Melissa P Lokugamage, and David Loughrey, and Elisa Schrader Echeverri, and Ana Cristian, and Marine Z C Hatit, and Philip J Santangelo, and Kun Zhao, and James E Dahlman
October 1990, Clinical genetics,
Kalina Paunovska, and Alejandro J Da Silva Sanchez, and Melissa P Lokugamage, and David Loughrey, and Elisa Schrader Echeverri, and Ana Cristian, and Marine Z C Hatit, and Philip J Santangelo, and Kun Zhao, and James E Dahlman
December 2006, The Journal of biological chemistry,
Kalina Paunovska, and Alejandro J Da Silva Sanchez, and Melissa P Lokugamage, and David Loughrey, and Elisa Schrader Echeverri, and Ana Cristian, and Marine Z C Hatit, and Philip J Santangelo, and Kun Zhao, and James E Dahlman
March 2007, Biochemical and biophysical research communications,
Kalina Paunovska, and Alejandro J Da Silva Sanchez, and Melissa P Lokugamage, and David Loughrey, and Elisa Schrader Echeverri, and Ana Cristian, and Marine Z C Hatit, and Philip J Santangelo, and Kun Zhao, and James E Dahlman
October 2000, The Journal of biological chemistry,
Kalina Paunovska, and Alejandro J Da Silva Sanchez, and Melissa P Lokugamage, and David Loughrey, and Elisa Schrader Echeverri, and Ana Cristian, and Marine Z C Hatit, and Philip J Santangelo, and Kun Zhao, and James E Dahlman
April 1986, Proceedings of the National Academy of Sciences of the United States of America,
Copied contents to your clipboard!